Hadfield KD - Search Results

1

Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients.

Ferraldeschi R, Arnedos M, Hadfield KD, A'Hern R, Drury S, Wardley A, Howell A, Evans DG, Roberts SA, Smith I, Newman WG, Dowsett M. Ferraldeschi R, et al. Among authors: hadfield kd. Breast Cancer Res Treat. 2012 Jun;133(3):1191-8. doi: 10.1007/s10549-012-2010-z. Epub 2012 Mar 15. Breast Cancer Res Treat. 2012. PMID: 22418701

2

Pharmacogenetics of aromatase inhibitors.

Hadfield KD, Newman WG. Hadfield KD, et al. Pharmacogenomics. 2012 Apr;13(6):699-707. doi: 10.2217/pgs.12.28. Pharmacogenomics. 2012. PMID: 22515612 Review.

3

Impaired tamoxifen metabolism reduces survival in familial breast cancer patients.

Newman WG, Hadfield KD, Latif A, Roberts SA, Shenton A, McHague C, Lalloo F, Howell S, Evans DG. Newman WG, et al. Among authors: hadfield kd. Clin Cancer Res. 2008 Sep 15;14(18):5913-8. doi: 10.1158/1078-0432.CCR-07-5235. Clin Cancer Res. 2008. PMID: 18794105

4

Breast cancer susceptibility variants alter risks in familial disease.

Latif A, Hadfield KD, Roberts SA, Shenton A, Lalloo F, Black GC, Howell A, Evans DG, Newman WG. Latif A, et al. Among authors: hadfield kd. J Med Genet. 2010 Feb;47(2):126-31. doi: 10.1136/jmg.2009.067256. Epub 2009 Jul 16. J Med Genet. 2010. PMID: 19617217

5

EGFR and KRAS mutational analysis and their correlation to survival in pancreatic and periampullary cancer.

Oliveira-Cunha M, Hadfield KD, Siriwardena AK, Newman W. Oliveira-Cunha M, et al. Among authors: hadfield kd. Pancreas. 2012 Apr;41(3):428-34. doi: 10.1097/MPA.0b013e3182327a03. Pancreas. 2012. PMID: 22422135

6

RASSF1A polymorphism in familial breast cancer.

Bergqvist J, Latif A, Roberts SA, Hadfield KD, Lalloo F, Howell A, Evans DG, Newman WG. Bergqvist J, et al. Among authors: hadfield kd. Fam Cancer. 2010 Sep;9(3):263-5. doi: 10.1007/s10689-010-9335-8. Fam Cancer. 2010. PMID: 20361264

7

UGT1A1*28 genotype predicts gastrointestinal toxicity in patients treated with intermediate-dose irinotecan.

Ferraldeschi R, Minchell LJ, Roberts SA, Tobi S, Hadfield KD, Blackhall FH, Mullamitha S, Wilson G, Valle J, Saunders M, Newman WG. Ferraldeschi R, et al. Among authors: hadfield kd. Pharmacogenomics. 2009 May;10(5):733-9. doi: 10.2217/pgs.09.20. Pharmacogenomics. 2009. PMID: 19450125

8

Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas.

Smith MJ, O'Sullivan J, Bhaskar SS, Hadfield KD, Poke G, Caird J, Sharif S, Eccles D, Fitzpatrick D, Rawluk D, du Plessis D, Newman WG, Evans DG. Smith MJ, et al. Among authors: hadfield kd. Nat Genet. 2013 Mar;45(3):295-8. doi: 10.1038/ng.2552. Epub 2013 Feb 3. Nat Genet. 2013. PMID: 23377182

9

Isolated unilateral vestibular schwannomas do not harbor HRAS mutations.

Smith MJ, Hadfield KD, Ramsden RT, Rutherford SA, King AT, Newman WG, Evans DG. Smith MJ, et al. Among authors: hadfield kd. Am J Med Genet A. 2010 Jun;152A(6):1586-7. doi: 10.1002/ajmg.a.33409. Am J Med Genet A. 2010. PMID: 20503341 No abstract available.

10

SMARCB1 mutations are not a common cause of multiple meningiomas.

Hadfield KD, Smith MJ, Trump D, Newman WG, Evans DG. Hadfield KD, et al. J Med Genet. 2010 Aug;47(8):567-8. doi: 10.1136/jmg.2009.075721. Epub 2010 May 14. J Med Genet. 2010. PMID: 20472658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters